Notice of Execution of Letter of Intent for Exclusive Distribution Rights of Korean-made Carbomer for the Chinese Pharmaceutical Excipients Market
Shoko Co., Ltd. has signed an LOI with Hannong Chemicals Inc. (Korea) to secure exclusive distribution rights for Carbomer in China's pharmaceutical excipients market, targeting DMF registration by summer 2026.
📋 Article Processing Timeline
- 📰 Published: April 7, 2026 at 18:00
- 🔍 Collected: April 7, 2026 at 09:01
- 🤖 AI Analyzed: April 21, 2026 at 01:49 (328h 47m after Collected)
Shoko Co., Ltd. (Headquarters: Minato-ku, Tokyo; President: Kentaro Watanabe; hereinafter 'Shoko'), a comprehensive trading company of materials such as chemicals, synthetic resins, metals, and ceramics, announces the signing of a Letter of Intent ('LOI') aimed at concluding an exclusive distribution agreement. The agreement concerns Carbomer, a water-soluble thickener and gelling agent manufactured by Hannong Chemicals Inc. (Anyang, Gyeonggi-do, Korea; hereinafter 'Hannong Chemicals'), and targets the pharmaceutical excipients market in China.
## Purpose of the Agreement
This LOI confirms the basic conditions toward concluding an exclusive distribution agreement for Carbomer, which is currently sold mainly as a cosmetic raw material, to expand its application into the Chinese domestic pharmaceutical excipients market (for uses compliant with pharmaceutical excipient standards).
## Future Developments
Moving forward, Shoko and Hannong Chemicals will proceed with discussions regarding details such as compliance with relevant laws and regulations in China, quality and supply systems, and commercial terms, aiming to conclude the final agreement.
Concurrently, we will advance the registration of the Drug Master File (DMF) required for the sale of pharmaceutical excipients in China (scheduled around summer 2026). We will also actively cultivate sales channels within China so that sales can commence immediately upon DMF registration.
Company Name: Shoko Co., Ltd.
Address: 31F Tamachi Station Tower N, 3-1-1 Shibaura, Minato-ku, Tokyo
Representative: Kentaro Watanabe, President and Representative Director
Established: May 1947
Overseas Bases: China, Korea, Taiwan, Thailand
URL: https://www.shoko.co.jp/
## Purpose of the Agreement
This LOI confirms the basic conditions toward concluding an exclusive distribution agreement for Carbomer, which is currently sold mainly as a cosmetic raw material, to expand its application into the Chinese domestic pharmaceutical excipients market (for uses compliant with pharmaceutical excipient standards).
## Future Developments
Moving forward, Shoko and Hannong Chemicals will proceed with discussions regarding details such as compliance with relevant laws and regulations in China, quality and supply systems, and commercial terms, aiming to conclude the final agreement.
Concurrently, we will advance the registration of the Drug Master File (DMF) required for the sale of pharmaceutical excipients in China (scheduled around summer 2026). We will also actively cultivate sales channels within China so that sales can commence immediately upon DMF registration.
Company Name: Shoko Co., Ltd.
Address: 31F Tamachi Station Tower N, 3-1-1 Shibaura, Minato-ku, Tokyo
Representative: Kentaro Watanabe, President and Representative Director
Established: May 1947
Overseas Bases: China, Korea, Taiwan, Thailand
URL: https://www.shoko.co.jp/